Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.66M Sell
20,666
-5,172
-20% -$605K 0.04% 305
2026
Q1
$3.11M Sell
25,838
-21,956
-46% -$2.53M 0.06% 254
2025
Q4
$5.03M Buy
47,794
+79
+0.2% +$7.42K 0.09% 161
2025
Q3
$4M Sell
47,715
-387
-0.8% -$31.9K 0.08% 176
2025
Q2
$3.81M Sell
48,102
-15,467
-24% -$1.23M 0.09% 176
2025
Q1
$5.71M Buy
63,569
+30,274
+91% +$2.83M 0.15% 96
2024
Q4
$3.31M Sell
33,295
-9,195
-22% -$948K 0.09% 168
2024
Q3
$4.83M Sell
42,490
-6,225
-13% -$740K 0.15% 121
2024
Q2
$6.03M Buy
48,715
+10,746
+28% +$1.38M 0.2% 87
2024
Q1
$5.01M Sell
37,969
-1,039
-3% -$128K 0.17% 103
2023
Q4
$4.25M Sell
39,008
-1,467
-4% -$152K 0.17% 104
2023
Q3
$4.17M Buy
40,475
+5,360
+15% +$578K 0.19% 94
2023
Q2
$4.05M Sell
35,115
-1,242
-3% -$141K 0.18% 93
2023
Q1
$3.87M Sell
36,357
-520
-1% -$56.1K 0.19% 102
2022
Q4
$3.8M Sell
36,877
-384
-1% -$39.3K 0.19% 97
2022
Q3
$3.78M Buy
37,261
+3,169
+9% +$283K 0.22% 93
2022
Q2
$2.98M Buy
34,092
+13,181
+63% +$1.17M 0.17% 101
2022
Q1
$1.72M Sell
20,911
-40
-0.2% -$3.15K 0.11% 129
2021
Q4
$1.61M Buy
20,951
+547
+3% +$43.6K 0.11% 135
2021
Q3
$1.53M Buy
20,404
+6,129
+43% +$466K 0.13% 119
2021
Q2
$1.11M Sell
14,275
-1,495
-9% -$111K 0.1% 155
2021
Q1
$1.16M Sell
15,770
-328
-2% -$24.2K 0.13% 135
2020
Q4
$1.27M Sell
16,098
-1,693
-10% -$129K 0.17% 118
2020
Q3
$1.41M Buy
17,791
+100
+0.6% +$7.83K 0.2% 100
2020
Q2
$1.3M Buy
17,691
+1,725
+11% +$130K 0.2% 94
2020
Q1
$1.17M Buy
15,966
+1,137
+8% +$89.4K 0.22% 95
2019
Q4
$1.29M Buy
14,829
+2,662
+22% +$219K 0.22% 91
2019
Q3
$977K Buy
12,167
+589
+5% +$47.2K 0.19% 94
2019
Q2
$927K Buy
11,578
+5,450
+89% +$417K 0.21% 94
2019
Q1
$487K Buy
6,128
+206
+3% +$15.4K 0.12% 143
2018
Q4
$432K Sell
5,922
-1,505
-20% -$106K 0.11% 149
2018
Q3
$560K Buy
7,427
+1,471
+25% +$93.7K 0.15% 139
2018
Q2
$345K Sell
5,956
-8,901
-60% -$502K 0.1% 154
2018
Q1
$772K Sell
14,857
-446
-3% -$24.1K 0.29% 61
2017
Q4
$827K Buy
15,303
+1,279
+9% +$70.9K 0.39% 62
2017
Q3
$861K Sell
14,024
-407
-3% -$24.7K 0.53% 36
2017
Q2
$866K Sell
14,431
-305
-2% -$18.6K 0.6% 29
2017
Q1
$894K Buy
14,736
+6,147
+72% +$373K 0.68% 33
2016
Q4
$512K Hold
8,589
0.49% 38
2016
Q3
$512K Buy
8,589
+21
+0.2% +$1.23K 0.47% 39
2016
Q2
$471K Sell
8,568
-21
-0.2% -$1.12K 0.41% 47
2016
Q1
$434K Buy
8,589
+2,012
+31% +$98.5K 0.34% 53
2015
Q4
$331K Buy
6,577
+412
+7% +$20.8K 0.24% 37
2015
Q3
$291K Sell
6,165
-1,099
-15% -$58.4K 0.94% 37
2015
Q2
$395K Buy
+7,264
New +$407K 0.18% 89

Other funds holding MRK

RFG Advisory's MRK Position: Q2 2026 in Review

RFG Advisory reduced its Merck (MRK) stake by 20% in Q2 2026, selling an estimated $605K and leaving 20,666 shares worth $2.66M. The position accounts for 0.04% of the portfolio, ranked #305.

RFG Advisory first reported a position in MRK in Q2 2015 and has held it in 45 quarters since. The position peaked at $6.03M in Q2 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • RFG Advisory held 20,666 shares of Merck worth $2.66M as of Q2 2026.
  • RFG Advisory sold 5,172 Merck shares in Q2 2026, an estimated $605K.
  • Merck made up 0.04% of RFG Advisory's portfolio in Q2 2026, its #305 holding.
  • RFG Advisory first reported a position in Merck in Q2 2015 and has held it in 45 quarters since.
  • RFG Advisory's Merck position peaked at $6.03M in Q2 2024.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.